Stage III Prostate Adenocarcinoma AJCC v7
specificStage II includes: IIA (T1a-c, N0, M0, PSA less than 20, Gleason 7); (T1a-c, N0, M0, PSA equal or more than 10 and less than 20, Gleason equal or less than 6); (T2a, N0, M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA less than 20, Gleason equal or less than 7); (T2b, N0, M0, PSA X, Gleason X); IIB (T2c, N0, M0, Any PSA, Any Gleason); (T1-2, N0, M0, PSA equal or more than 20, Any Gleason); (T1-2, N0, M0, Any PSA, Gleason equal or more than 8). T1a: Tumor incidental histol
61
Centers
47
Active Trials
—
Cancer Funding
Top Centers for Stage III Prostate Adenocarcinoma AJCC v7(61)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive High-Volume Research Center | 73.0 |
| 2 | University of Michigan Rogel Cancer CenterAnn Arbor, MI NCI Comprehensive Active Research Program | 56.0 |
| 3 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 56.0 |
| 4 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive Active Research Program | 56.0 |
| 5 | UPMC Hillman Cancer CenterPittsburgh, PA NCI Comprehensive Active Research Program | 56.0 |
| 6 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 56.0 |
| 7 | Vanderbilt-Ingram Cancer CenterNashville, TN NCI Comprehensive Active Research Program | 56.0 |
| 8 | NCI Comprehensive Active Research Program | 56.0 |
| 9 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 56.0 |
| 10 | NCI Comprehensive Active Research Program | 56.0 |
| 11 | NCI Comprehensive Active Research Program | 56.0 |
| 12 | NCI Comprehensive Active Research Program | 56.0 |
| 13 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 56.0 |
| 14 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 56.0 |
| 15 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 56.0 |
| 16 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 56.0 |
| 17 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 56.0 |
| 18 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program | 56.0 |
| 19 | UC Davis Comprehensive Cancer CenterSacramento, CA NCI Comprehensive Active Research Program | 56.0 |
| 20 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program | 56.0 |
| 21 | NCI Clinical Active Research Program | 56.0 |
| 22 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program | 56.0 |
| 23 | Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program | 56.0 |
| 24 | Cedars-Sinai CancerLos Angeles, CA Active Research Program | 56.0 |
| 25 | Wilmot Cancer Institute, UR MedicineRochester, NY NCI Clinical Active Research Program | 56.0 |
| 26 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 56.0 |
| 27 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 56.0 |
| 28 | Sidney Kimmel Comprehensive Cancer Center at JeffersonPhiladelphia, PA NCI Comprehensive Active Research Program | 56.0 |
| 29 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 56.0 |
| 30 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program | 56.0 |
| 31 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 56.0 |
| 32 | University of Illinois Cancer CenterChicago, IL Active Research Program | 56.0 |
| 33 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive Active Research Program | 56.0 |
| 34 | UAMS Winthrop P. Rockefeller Cancer InstituteLittle Rock, AR Active Research Program | 56.0 |
| 35 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive Active Research Program | 56.0 |
| 36 | Cancer Center at IllinoisUrbana, IL Active Research Program | 56.0 |
| 37 | Stony Brook Cancer CenterStony Brook, NY Active Research Program | 56.0 |
| 38 | Penn State Cancer InstituteHershey, PA Active Research Program | 56.0 |
| 39 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 56.0 |
| 40 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 56.0 |
| 41 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program | 56.0 |
| 42 | Georgia Cancer Center, Augusta UniversityAugusta, GA Active Research Program | 56.0 |
| 43 | The University of Vermont Cancer CenterBurlington, VT Active Research Program | 56.0 |
| 44 | Upstate Cancer CenterSyracuse, NY Active Research Program | 56.0 |
| 45 | Louisiana Cancer Research CenterNew Orleans, LA Active Research Program | 56.0 |
| 46 | Princess Margaret Cancer CentreToronto, ON Active Research Program | 56.0 |
| 47 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | 33.9 |
| 48 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive | 33.9 |
| 49 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive | 33.9 |
| 50 | Duke Cancer InstituteDurham, NC NCI Comprehensive | 33.9 |
| 51 | NCI Comprehensive | 33.9 |
| 52 | OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive | 33.9 |
| 53 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive | 33.9 |
| 54 | NCI Comprehensive | 33.9 |
| 55 | Atrium Health Wake Forest Baptist Comprehensive Cancer CenterWinston-Salem, NC NCI Comprehensive | 33.9 |
| 56 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical | 33.9 |
| 57 | Boston University Cancer CenterBoston, MA | 33.9 |
| 58 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 33.9 |
| 59 | 33.9 | |
| 60 | Northwell Health Cancer InstituteNew York, NY | 33.9 |
| 61 | University of Texas Medical Branch Cancer CenterGalveston, TX | 33.9 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →